This week’s episode of “WisBusiness: the Podcast” features an interview with Dr. Ulrich Broeckel, founder and CEO of RPRD Diagnostics.
He’s also a professor in the Departments of Pediatrics, Medicine and Physiology at the Medical College of Wisconsin, with over 20 years of experience working with genetics and genomics and 10 years in clinical diagnostics. The business is a clinical diagnostic lab focused on precision medicine, particularly in the field of pharmacogenetics. Its name stands for “right patient, right drug.”
“Pharmacogenetics is really the science and the application of genetic testing to find out which drug works for a particular patient,” he said. “We’re offering clinical testing, very comprehensive, for patients and health care providers and pharmacists who like to utilize this information to tailor, personalize the drug treatments.”
While his work at the MCW in Milwaukee relates to understanding genetic variations and their impact on human health and medical treatment, RPRD Diagnostics aims to put this understanding into practice and make related services more widely available.
“By including the information from a pharmacogenetic test, that you can either provide a better dosing or you can look for a better drug which works potentially better than the other one, or you can actually reduce the potential occurance of side effects,” he said.
Broeckel also provides his perspective on the rise of genetics testing, and the importance of personalized medicine in modern health care.
Listen to the podcast below, sponsored by UW-Madison:
